A pilot study on prevention of glucocorticoid induced diabetes mellitus by linaglipti
Not Applicable
- Conditions
- Patients scheduled administration of glucocorticoid
- Registration Number
- JPRN-UMIN000015588
- Lead Sponsor
- Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
Not provided
Exclusion Criteria
1) < 20 years old 2) Inability of internal use 3) Pregnancy 4) Glucocorticoid pulse therapy is scheduled 5) Malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of development of glucocorticoid induced diabetes mellitus within 1 month
- Secondary Outcome Measures
Name Time Method Concomitant insulin use Concomitant anti-diabetic drug Adverse effect Change in HbAic Change in HOMA-IR Change in glycoalbumin Change in 1.5-AG Change in adiponectin Change in glucagon Change in cortisol Change in leptin Change in serum and urine CPR